Masking Requirements Continue in Select Indoor Settings
April 25, 2022
As Ontario continues to effectively manage the sixth wave of COVID-19, the Chief Medical Officer of Health is maintaining existing provincial masking requirements in select higher-risk indoor settings until June 11, 2022.
“To protect our progress in managing this latest wave, I am maintaining masking requirements in specific public settings where individuals who are, or may be, at increased risk of severe outcomes, are in close contact for extended periods of time,” said Dr. Kieran Moore, Chief Medical Officer of Health. “Continuing to follow masking requirements and keeping up to date with COVID-19 vaccinations are the best ways we can prevent transmission and protect our friends, families, and our communities.”
Provincial masking requirements which were set to expire on April 27, 2022 are being extended in current settings until 12:00 a.m. on June 11, 2022, including:
A complete list of settings where masking requirements continue to apply is available online.
The Chief Medical Officer of Health will also maintain the CMOH Directives currently in effect until June 11, 2022, after which the ministry will issue guidance on personal protective equipment recommendations for infection prevention and control in health care settings.
Given the province’s high vaccination rates, expansion of booster doses, as well as the arrival of antivirals, Ontario has the tools necessary to manage the impact of the virus. The Chief Medical Officer of Health and the province will continue to monitor key indicators and the COVID-19 situation across Ontario.
Expanding Ontario’s Tools to Manage COVID-19 and Stay Open
While the province adapts to managing and living with COVID-19, the Ontario government is using every tool available to protect hospital capacity and ensure Ontario can stay open. This includes continuing masking in high-risk settings, expanding eligibility for fourth doses of the COVID-19 vaccine and expanding access to antiviral treatments such as Paxlovid.
To further expand the tools available to protect Ontarians and reduce hospital visits, the province will start to receive supplies of Evusheld, an antibody treatment for immunocompromised individuals who are not positive for COVID-19 at the time of administration. Following two single-dose injections, the treatment provides protection from COVID-19 for six months.
Based on advice from the Canadian Agency for Drugs and Technologies in Health (CADTH), Evusheld will be available to individuals with the highest-risk of a severe outcome from COVID-19 in the coming weeks, including:
“Thanks to the province’s high vaccination rates as well as an increase in antiviral treatment availability and eligibility, we have been able to cautiously and gradually reopen Ontario,” said Christine Elliott, Deputy Premier and Minister of Health. “Vaccination remains our best protection against COVID-19, and I strongly recommend that everyone stays up to date with their vaccinations by receiving the dose you are eligible for as soon as you can. As with vaccines for other diseases, you are protected best when you stay up to date.”